Cancer cells have evolved mechanisms to escape the body’s immune defense. Agents that prevent immune escape are attractive targets for the development of new cancer therapies. Scientists have now developed a new cell-based test system to identify immunoregulatory modulators. Screening a library of over 150,000 substances revealed several potent substances with unprecedented structure.
